Lupin receives USD 25 million from AbbVie for successful initiation of Phase 1 clinical studies
Lupin and AbbVie inked the licensing, development, and commercialisation agreement in 2018 for this novel oncology drug to treat…
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.